User profiles for K. Nilgiriwala

Kayzad Nilgiriwala

Assistant Director (Research) at The Foundation for Medical Research (FMR)
Verified email at fmrindia.org
Cited by 1187

[HTML][HTML] The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis

…, JV Kus, K Todt, K Holt, KS Nilgiriwala… - The Lancet …, 2022 - thelancet.com
Background Molecular diagnostics are considered the most promising route to achievement
of rapid, universal drug susceptibility testing for Mycobacterium tuberculosis complex (MTBC…

Same-day diagnostic and surveillance data for tuberculosis via whole-genome sequencing of direct respiratory samples

…, C del Ojo Elias, M Loose, K Nilgiriwala… - Journal of clinical …, 2017 - Am Soc Microbiol
… experiments resulted in correct identification of the H57D mutation in pncA that confers
pyrazinamide resistance in BCG, but in the 5% spike, this call was filtered out as it only had k-mer …

Retroactivity controls the temporal dynamics of gene transcription

S Jayanthi, KS Nilgiriwala, D Del Vecchio - ACS synthetic biology, 2013 - ACS Publications
… In the limit in which the dissociation constant K d (= k off /(p T k on )) is very small compared
to z, we obtain that the main effect of retroactivity is to increase the point of half maximal …

Cloning and Overexpression of Alkaline Phosphatase PhoK from Sphingomonas sp. Strain BSAR-1 for Bioprecipitation of Uranium from Alkaline Solutions

KS Nilgiriwala, A Alahari, AS Rao… - Applied and …, 2008 - Am Soc Microbiol
Cells of Sphingomonas sp. strain BSAR-1 constitutively expressed an alkaline phosphatase,
which was also secreted in the extracellular medium. A null mutant lacking this alkaline …

[HTML][HTML] Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis

…, DM Cirillo, C Rodrigues, KS Nilgiriwala… - The Lancet …, 2023 - thelancet.com
Background Bedaquiline is a core drug for the treatment of multidrug-resistant tuberculosis;
however, the understanding of resistance mechanisms is poor, which is hampering rapid …

[HTML][HTML] Cost-effectiveness of GeneXpert and LED-FM for diagnosis of pulmonary tuberculosis: A systematic review

KD Sagili, M Muniyandi, KS Nilgiriwala… - PLoS …, 2018 - journals.plos.org
Background Early and accurate diagnosis of tuberculosis is a priority for TB programs globally
to initiate treatment early and improve treatment outcomes. Currently, Ziehl–Neelsen (ZN) …

[HTML][HTML] High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai …

…, P Dev, M Merker, I Barilar, C Utpatel, K Nilgiriwala… - Genome medicine, 2022 - Springer
Background Multidrug-resistant (MDR) Mycobacterium tuberculosis complex (MTBC) strains
are a serious health problem in India, also contributing to one-fourth of the global MDR …

Whole genome sequencing of clinical strains of Mycobacterium tuberculosis from Mumbai, India: a potential tool for determining drug-resistance and strain lineage

A Chatterjee, K Nilgiriwala, D Saranath, C Rodrigues… - Tuberculosis, 2017 - Elsevier
Amplification of drug resistance in Mycobacterium tuberculosis (M.tb) and its transmission
are significant barriers in controlling tuberculosis (TB) globally. Diagnostic inaccuracies and …

[HTML][HTML] Antibiotic Resistance Characterization of Environmental E. coli Isolated from River Mula-Mutha, Pune District, India

…, R Macaden, D Saranath, K Nilgiriwala… - International journal of …, 2018 - mdpi.com
In the current study, ceftazidime- and ciprofloxacin-resistant—or dual drug-resistant (DDR)—E.
coli were isolated from river Mula-Mutha, which flows through rural Pune district and …

Genomic sequencing from sputum for tuberculosis disease diagnosis, lineage determination, and drug susceptibility prediction

K Nilgiriwala, MS Rabodoarivelo, MB Hall… - Journal of Clinical …, 2023 - Am Soc Microbiol
Universal access to drug susceptibility testing for newly diagnosed tuberculosis patients is
recommended. Access to culture-based diagnostics remains limited, and targeted molecular …